Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: JWN stock price vs UNH: inconclusive — current versus $51.07 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at UNH's multiple
Implied fair value · at JWN's multiple
Needs JWN P/E.
Snapshot Sep 10, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
16 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 82% equity / 18% debt · EV / Revenue 0.90x · EV proxy / EBITDA proxy 18.58x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Nordstrom, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
UnitedHealth Group Incorporated · implied price per share
Bear
$316.48
Base
$378.28
Bull
$461.66
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
TJX COMPANIES INC /DE/
JWN vs TJX
ROSS STORES, INC.
JWN vs ROST
Macy's, Inc.
JWN vs M
KOHLS Corp
JWN vs KSS
Walmart Inc.
JWN vs WMT
COSTCO WHOLESALE CORP /NEW
JWN vs COST
HUMANA INC
JWN vs HUM
CENTENE CORP
JWN vs CNC
CVS Health Corporation
JWN vs CVS
Elevance Health, Inc.
JWN vs ELV
MOLINA HEALTHCARE, INC.
JWN vs MOH
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe JWN can sustain its higher ROIC and margin profile while narrowing the gap in growth quality, then a cautious long view may be justified because the DCF range tops out below the $54.50 implied price, but the data support only a mixed, not strong, valuation case.
The provided implied price from the P/E framework is $54.50, which is close to UNH-implied range of $55.18 to $154.33 and above the DCF range of $36.10 to $48.84. That suggests the stock is neither a deep discount nor clearly expensive based on the supplied outputs, but the absence of JWN’s own P/E, P/S, and EV-based multiples limits precision.
Supporting Metrics
